Regenten Patient

Smith+Nephew launch REGENETEN Bioinductive Implant in India for rotator cuff repair

Smith+Nephew, the global medical technology firm, has officially introduced its REGENETEN Bioinductive Implant in the Indian market. This innovative implant has already transformed the approach to rotator cuff procedures worldwide, having been used in over 100,000 surgeries.

The REGENETEN Bioinductive Implant, crafted from collagen, leverages the body’s natural healing response to stimulate the growth of new tendon-like tissue. By augmenting the existing tendon and altering the course of disease progression, this implant is inserted arthroscopically through a small incision precisely over the affected rotator cuff tendon area. Sized similarly to a postage stamp, the implant gradually becomes indiscernible within six months. During this period, the development of new tendon-like tissue and organized collagen, indicative of functional loading, takes place.

Having already demonstrated its clinical effectiveness over a span of more than a decade through 18 studies encompassing the entire spectrum of rotator cuff issues, the REGENETEN Bioinductive Implant enters the Indian market. Its applications range from addressing partial thickness tears to addressing substantial full-thickness tears of varying sizes. A recent triple-blinded randomized controlled trial underscored the implant’s significance, revealing an impressive 86% reduction in re-tear rates at 12 months when combined with conventional rotator cuff repair procedures, as compared to conventional surgery alone.

The prevalence of rotator cuff ailments in India was estimated at 150,000 cases in 2022, leading to approximately 28,000 rotator cuff repair surgeries. Anticipated growth indicates that the total rotator cuff repair market in India will encompass 33,000 cases in 2023 and reach 39,000 in 2024, showcasing a year-over-year expansion of 15%.

Joaquin Lasso, Managing Director, South Asia for Smith+Nephew, expressed enthusiasm about the REGENETEN Bioinductive Implant’s introduction in India. Highlighting the evident clinical success, Lasso emphasized the implant’s transformative impact on rotator cuff repair, yielding positive outcomes for numerous patients around the globe.

The REGENETEN Bioinductive Implant forms a pivotal component of Smith+Nephew’s comprehensive Advanced Healing Solutions portfolio, which is redefining the landscape of biological healing in rotator cuff repair.

© Smith & Nephew

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe